Evidence map›Paper›PMID 38547440›Full record

ArticleJCO global oncology2024

Early-Onset Colorectal Cancer in Egypt: Pathological Characters, Patterns of Care, and Survival Compared to Average-Age Onset Colorectal Cancer: A Retrospective Multicenter Study.

Noha Rashad, Salem Eid Salem, Mohamed A M Meheissen, Ghada Refaat, Heba Mahmoud Sami, Abdelsalam Temerik, Nashwa Kordy, Mina A Daniel, Mohamed El-Kaffas, Mohamed Esam and 8 more

Abstract readMulticenter Study
In one paragraph

Article in JCO global oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Expression of VISTA on T cells in patients with cancer colon.Journal of the Egyptian National Cancer Institute · 2025
    Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Noha RashadMedical Oncology Department, Shefaa Al-Orman Oncology Hospital, Luxor, Egypt.ORCID 0000-0002-3684-9271
Salem Eid SalemDepartment of Medical Oncology, National Cancer Institute (NCI), Cairo University, Cairo, Egypt.ORCID 0000-0002-6204-5031
Mohamed A M MeheissenClinical Oncology Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
Ghada RefaatClinical Oncology and Nuclear Medicine Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Heba Mahmoud SamiDepartment of Medical Oncology, National Cancer Institute (NCI), Cairo University, Cairo, Egypt.
Abdelsalam TemerikMedical Oncology Department, Shefaa Al-Orman Oncology Hospital, Luxor, Egypt.
Nashwa KordyBiostatistics, Epidemiology and Science Computing Department, Shefaa Al-Orman Oncology Hospital, Luxor, Egypt.ORCID 0000-0001-7039-906X
Mina A DanielMedical Oncology Department, Shefaa Al-Orman Oncology Hospital, Luxor, Egypt.
Mohamed El-KaffasMedical Oncology Department, Shefaa Al-Orman Oncology Hospital, Luxor, Egypt.
Mohamed EsamMedical Oncology Department, Shefaa Al-Orman Oncology Hospital, Luxor, Egypt.
Hazem El MansyDepartment of Cancer Management and Research, Medical Research Institute, University of Alexandria, Alexandria, Egypt.ORCID 0000-0003-0725-6773
Yasser ElkermDepartment of Cancer Management and Research, Medical Research Institute, University of Alexandria, Alexandria, Egypt.
Amr Abdelaziz ElsaidClinical Oncology Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
Abdelsalam Attia IsmailClinical Oncology Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
Mohyeldin Saber AbdelhalimClinical Oncology Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt.ORCID 0000-0002-9882-8759
Lamiaa Moustafa AhmadClinical Oncology and Nuclear Medicine Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Mai Akram MahmoudClinical Oncology and Nuclear Medicine Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Eman D El DesoukyDepartment of Biostatistics and Epidemiology, National Cancer Institute, Cairo University, Cairo, Egypt.ORCID 0000-0002-4517-4181

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeEarly-onset colorectal cancer (EOCRC) is a rising health problem. The incidence of EOCRC has increased over the past 2 decades all over the world. Reports from Egypt since the 1990s have reported a higher incidence among young populations with no identifiable risk factors. The aim of this study was to assess EOCRC in Egypt regarding incidence, characteristics, treatment pattern, and survival compared with average age onset and elderly patients. MATERIALS AND

methodsThis was a retrospective, record-based, cohort study combining data from four different cancer centers in Egypt. We grouped patients according to age into three categories: the EOCRC group for patients age ≤45 years and the average age onset and elderly cancer group (for patients age ≥65 years).

resultsThe study included 1,310 patients with histopathologically proven colorectal cancer, representing four different geographical areas in Egypt. Patients with EOCRC represented 42.4% of the study population. Female patients were 50.6% among the EOCRC group and 52.5% among the average age group. Rectal tumors were significantly higher in EOCRC (54.7%

conclusionA comprehensive framework for the study of EOCRC is required in Egypt as well as a genomic analysis to identify possible underlying genetic alterations responsible for the high incidence of EOCRC.

Indexed as

Colorectal NeoplasmsAgedCohort StudiesDisease-Free SurvivalEgyptFemaleHumansMiddle AgedRetrospective Studies

Identifiers

PMID38547440
PMCPMC10994464

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.